LY3954068 clinical trials

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

This study looks at a new medicine called LY3954068 for people with early Alzheimer's disease. Researchers want to see if it's safe, how it moves through the body, and if it affects signs of the disease. Participants will receive the medicine or a dummy treatment through an injection into the spinal fluid.